CSI Market
Sign In | Register

Sab Biotherapeutics Inc (SABS) Annual Balance Sheets

Annual · GAAP · USD millions
Access SABS quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Sab Biotherapeutics Inc's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent10.50
Short-term Investments, Total86.09
Cash & Short-term Investments96.00
Accounts receivable0.00
Accrued Investment Income Receivable AC0.95
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.51
Total Current Assets101.05
Equipment/Property/Plant Net13.31
Long-term investments46.89
Deferred Finance Costs, Net DE10.15
Other Assets, Noncurrent58.30
Restricted Cash Current-
Operating Lease Right Of Use Asset2.60
Finance Lease Right Of Use Asset3.50
Total Assets172.81
Liabilities
Accounts Payable, Current AC3.15
Notes Payable, Current NO0.00
Other Liabilities, Current7.54
Total Current Liabilities10.68
Convertible Debt, Noncurrent LO0.00
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE5.64
Other liabilities, Noncurrent5.00
Forward Share Purchase Liability-
Operating Lease Liability Current0.80
Finance Lease Liability Current0.15
Due To Related Parties Current Excluding Notes Payable-
Deferred Income Current-
Operating Lease Liability Noncurrent1.88
Finance Lease Liability Noncurrent3.12
Total Liabilities21.32
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value-5.52
Additional Paid In Capital Common Stock267.72
Retained Earnings / Accumulated Deficit-110.90
Other Equity0.19
Common Stockholder's Equity151.49
Preferred Stockholder's Equity0.00
Total Stockholder's Equity151.49
Liabilities & Stockholder's Equity172.81
4 historic quarters locked

Sign in to unlock the full Sab Biotherapeutics Inc balance sheet history.

Sign In Create Free Account

About Sab Biotherapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001833214-26-000003

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License